New York
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
From
To
New York
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Investments Opinions
Issued on behalf of Helus Pharma™
Investments Opinions
Issued on behalf of Helus Pharma™
New York
NEW YORK, July 16, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating AtaiBeckley Inc. (NASDAQ: ATAI) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, AtaiBeckley shareholders are expected to receive $6.75 per share in cash, plus up to $2.50 per share in the form of a Contingent Value Right entitling the holder to additional cash payments upon achievement of specified development and regulatory milestones related to the BPL-003 and VLS-01 programs. Is it a fair deal?
Banking Financial Services
MILWAUKEE, July 16, 2026 /PRNewswire/ -- Ademi LLP is investigating AtaiBeckley (Nasdaq: ATAI) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Eli Lilly.
Health Care Hospitals
AtaiBeckley's lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression
